Bridging for Lung Transplantation With Lumacaftor/Ivacaftor

Breathe - United Kingdom
doi 10.1183/20734735.019318
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Lumacaftor/Ivacaftor Reduces Pulmonary Exacerbations in Patients Irrespective of Initial Changes in FEV1

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2019English

Strategies for Pediatric Lung Transplantation: Bridging, Listing and Surgical Technique

Annals of Cardiothoracic Surgery
SurgeryCardiovascular MedicineCardiology
2020English

Cost Effectiveness of Ivacaftor and Lumacaftor Combination for the Treatment of Patients With Cystic Fibrosis in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Effect of One-Year Lumacaftor–ivacaftor Treatment on Glucose Tolerance Abnormalities in Cystic Fibrosis Patients

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2020English

Operative Technique for Lung Transplantation.

Thorax
PulmonaryRespiratory Medicine
1972English

Lung Transplantation

Einstein (São Paulo, Brazil)
Medicine
2015English

Lung Transplantation

2012English

Successful Bilateral Lung Transplantation for Lymphangiomatosis

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2008English

Mechanical Ventilation and Extracorporeal Membrane Oxygenation as a Bridging Strategy to Lung Transplantation: Significant Gains in Survival

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy